AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 59 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 444,439 | $3,644,000 | 3.88% |
| Broadfin Capital, LLC | 2,591,721 | $21,252,000 | 3.47% |
| ARMISTICE CAPITAL, LLC | 1,688,000 | $13,842,000 | 1.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,955,494 | $32,435,000 | 1.28% |
| NEXTHERA CAPITAL LP | 505,921 | $4,149,000 | 0.76% |
| Perceptive Advisors | 2,391,841 | $19,613,000 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 3,308,250 | $27,128,000 | 0.55% |
| KNOTT DAVID M | 158,555 | $1,300,000 | 0.52% |
| Ativo Capital Management LLC | 130,032 | $1,066,000 | 0.28% |
| Tekla Capital Management LLC | 624,288 | $5,119,000 | 0.20% |